831 related articles for article (PubMed ID: 17557081)
1. US biodefense--shocking and awful.
Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081
[No Abstract] [Full Text] [Related]
2. A shocking biodefense editorial.
Vanderwagen WC
Nat Biotechnol; 2007 Oct; 25(10):1083; author reply 1083-4. PubMed ID: 17921983
[No Abstract] [Full Text] [Related]
3. BRIEF REPORT: recent progress in biodefense countermeasure development.
Mair M
Biosecur Bioterror; 2005; 3(4):280-5. PubMed ID: 16392161
[No Abstract] [Full Text] [Related]
4. Legal issues surrounding public health emergencies.
Fidler DP
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):79-86. PubMed ID: 11880678
[No Abstract] [Full Text] [Related]
5. Optimizing active and passive countermeasures.
Kline CR
IEEE Eng Med Biol Mag; 2004; 23(1):102-9. PubMed ID: 15154265
[No Abstract] [Full Text] [Related]
6. Bioterrorism: an overview.
Peralta LA
Semin Perioper Nurs; 2001 Oct; 10(4):167-74. PubMed ID: 15129614
[TBL] [Abstract][Full Text] [Related]
7. Biodefense: who's in charge?
Sutton V
Health Matrix Clevel; 2003; 13(1):117-58. PubMed ID: 14569660
[No Abstract] [Full Text] [Related]
8. Obstacles to biodefence.
Nature; 2002 Sep; 419(6902):1. PubMed ID: 12214191
[No Abstract] [Full Text] [Related]
9. Assessing the threat of bioterrorism: are we ready?
Keenan PS; Kline J
Issue Brief (Commonw Fund); 2002 Apr; (535):1-8. PubMed ID: 11993502
[No Abstract] [Full Text] [Related]
10. Reducing the bioweapons threat: international collaboration efforts.
Eitzen EM
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):17-8. PubMed ID: 11880663
[No Abstract] [Full Text] [Related]
11. Observations from the Top Off exercise.
Inglesby TV
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):64-8. PubMed ID: 11880675
[No Abstract] [Full Text] [Related]
12. Biological and chemical bioterrorism agents.
Porche DJ
J Assoc Nurses AIDS Care; 2002; 13(5):57-64. PubMed ID: 12369391
[TBL] [Abstract][Full Text] [Related]
13. Cost/success projections for US biodefense countermeasure development.
Matheny J; Mair M; Smith B
Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
[No Abstract] [Full Text] [Related]
14. The far-reaching impact of bioterrorism. What the European Union is doing regarding deliberate releases of biological/chemical agents based on the events in the United States.
Gouvras G
IEEE Eng Med Biol Mag; 2002; 21(5):112-5. PubMed ID: 12405064
[No Abstract] [Full Text] [Related]
15. Legal preparedness for bioterrorism.
Matthews GW; Benjamin G; Mills SP; Parmet W; Misrahi JJ
J Law Med Ethics; 2002; 30(3 Suppl):52-6. PubMed ID: 12508503
[TBL] [Abstract][Full Text] [Related]
16. Combating bioterrorism with bioengineering.
Laxminarayan S; Kun LG
IEEE Eng Med Biol Mag; 2002; 21(5):21, 23-7. PubMed ID: 12405054
[No Abstract] [Full Text] [Related]
17. [Bioterrorism--real threat].
Wiackowski SK
Przegl Lek; 2004; 61 Suppl 3():33-5. PubMed ID: 15682939
[TBL] [Abstract][Full Text] [Related]
18. Biodefense. Army halts work at lab after finding untracked material.
Bhattacharjee Y
Science; 2009 Feb; 323(5916):861. PubMed ID: 19213883
[No Abstract] [Full Text] [Related]
19. Isolationism is not the answer to bioterrorism.
Singh JA; Singer PA
Nature; 2002 Dec; 420(6916):605. PubMed ID: 12478264
[No Abstract] [Full Text] [Related]
20. Epidemic response scenario: decision making in a time of plague.
O'Toole T; Inglesby TV
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):92-103. PubMed ID: 11880680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
